Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
| Mendus to participate in upcoming industry conferences | ||
| By: GlobeNewswire - 27 Feb 2024 | Back to overview list |
|
Press release Stockholm, Sweden, February 27, 2024 Mendus AB ("Mendus" publ; IMMU. ST), a biopharmaceutical company focused on immunotherapies targeting tumor recurrence, today announced that it will participate in the following upcoming industry conferences: 10th annual IO360° Summit New York, USA, February 27-29, 2024 CEO Erik Manting will participate in the 10th annual IO360° Summit, a conference dedicated to reporting on the latest advancements and data in Immuno-Oncology. Bio-Europe Spring Barcelona, Spain, March 18-20, 2024 Mendus CEO and business development will participate in Bio-Europe Spring for industry and investor meetings. https://informaconnect.com/bioeurope-spring/ Innate Killer Summit San Diego, USA, March 18-20, 2024 Director of Research Satwinder Kaur Singh will be expert speaker at the Innate Killer Summit. Dr Singh will present the application of dendritic cell biology to develop novel cancer immunotherapies, including Mendus NK cell platform. The presentation will be part of the CMC and Process Development Track held on March 19. For more information, please contact: About Mendus AB (publ) Attachment 
|
||
|
||
 | Back to overview list | |